— Know what they know.
Not Investment Advice
Also trades as: XRTX.V (TSXV) · $vol 0M

XRTX NASDAQ

XORTX Therapeutics Inc.
1W: +15.1% 1M: -35.7% 3M: -46.6% YTD: +93.0% 1Y: +66.6% 3Y: -53.0% 5Y: -96.2%
$1.10
+0.04 (+3.77%)
 
Weekly Expected Move ±21.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 22 · $2.0M mcap · 2M float · 30.44% daily turnover · Short 43% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -7.69.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$157K +2.5% ▲
Operating Income
-$5M +19.4% ▲
Net Income
-$4M +18.2% ▲
EPS (Diluted)
$-3.90 +50.6% ▲
EBITDA
-$4M -0.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$14K$56K$142K$0$157K
Gross Profit-$14K-$56K-$142K$0-$157K
Gross Margin—————
R&D Expenses$674K$6M$2M$264K$803K
SG&A Expenses$2M$3M$4M$3M$4M
Operating Expenses$3M$10M$6M$4M$4M
Operating Income-$3M-$10M-$6M-$4M-$5M
Operating Margin—————
Interest Expense$4K$0$0$0$0
Income Before Tax-$1M-$7M-$2M-$5M-$4M
Tax Expense$0$0$0$0$0
Net Income-$1M-$7M-$2M-$5M-$4M
Net Margin—————
EPS (Diluted)$-1.19$-4.72$-1.08$-1.65$-3.90
EBITDA-$1M-$7M-$2M-$4M-$4M
Shares Outstanding1M1M2M3M946925

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms